Tony Yen-Huei Tarn MS, PhD
After 24 years service in the Military School of Pharmacy, National Defense Medical Center (NDMC), Taiwan, Dr. Tarn retired and changed his career path to the hospital practice as the Director General of the Department of Pharmacy, Taipei City Hospital in Taipei, Taiwan. Dr. Tarn received his BS degree in Pharmacy from NDMC in 1980, MS degree in Clinical/Hospital Pharmacy program from University of Iowa in 1886, and PhD degree in Pharmacy Administrative and Behavioral Science from University of Arizona in 1993. His major interests are: pharmaceutical care practice, pharmacoeconomics and outcomes research, quality of life measurement, and creating stages for professional pharmacy practice. He is now the President of Taiwan Society of Pharmacoeconomics and Outcomes Research (TaSPOR) and a board member of the Western Pacific Pharmaceutical Forum of the Federation International Pharmaceutical (FIP).

Shanlian Hu MSc. MD 
Dr. Shanlian Hu is Professor of Health Economics, Health Management and Epidemiology. At present, he is holding the position of Director of Training Center for Health Management at School of Public Health, Fudan University (the former Shanghai Medical University), Director of Pharmacoeconomics Research and Evaluation Center of Fudan University. The Deputy Director of National Health Economic Institution of MOH and the Coordinator of China Network of Training and Research in Health Economics and Financing, which has been supported by the World Bank and Ministry of Health since 1991. Professor Hu has many other appointments in the academic and policy research field. He is a member of MOH Advisory Committee of Health Policy and Administration since 1996. He is one of the leading Professors in the key discipline of Social Medicine and Health Management approved by National Education Committee. He was appointed as member of Certification Committee of National Eradication of Poliomyelitis (1998-), Expanded Program of Immunization (1997-), Shanghai Advisory Committee of Health Reform and Development (1998-), National Medical Degree Education Committee (2000-), member of Advisory Committee on new type rural cooperative medical system (2004-). He was also invited as a Visiting Professor both in Zhejiang University and Southeast University. In 1997, the WHO West Pacific Regional Office nominated him as a member of the Committee of Health System Research. and re-elected as member of Steering Committee, Alliance of Health Policy and System Research in 2004.. Over the past decade, he was doing temporary consultant for the World Bank, UNDP and AUSAID in China, WHO in West Samoa, and UNICEF in Myanmar. He jointed the advisory group of World Bank to do the sector report “Financing Health Care: Issues and Options for China” in 1996, and wrote the health and nutrition chapter of 1997 China Human Development Report for UNDP. Recently, he joined the Health Sector Report for the World Bank in China. In the recent years, Professor Hu has been working in various research projects supported by MOH, MOLSS, Shanghai Bureau of Health, UNICEF, World Bank, WHO/TDR and Merck International Foundation. He is interested in urban health insurance reform, new rural cooperative medical system in impoverished areas, health access in urban poor, health system performance, evaluation epidemiology, drug policy and pharmacoeconomics, etc.

Isao Kamae MD, DrPH
Isao Kamae is a physician, Professor of Applied Medical Statistics and Health Decision Science, and Director of Information Center at Kobe University Graduate School of Medicine, and Kobe University Research Center for Urban Safety and Security since February 1997. He is also a Committee member for PE guidelines in Ministries of Japanese Government. He is recognized as one of the leaders in Japan for interdisciplinary research and education on innovative issues in pharmacoeconomocs and outcomes research. His educational record includes a master degree in information science, Kyoto University in 1979, a MD, Kobe University School of Medicine in 1985, a Master degree of Public Health in biostatistics, Harvard School of Public Health in 1988, where he was also the first Japanese to be awarded a Doctor of Public Health in health decision sciences of Harvard University in 1995. ISPOR is one of his major societies, honoring him with a representative of the conference co-chairs at the ISPOR First Asia-Pacific Conference in Kobe, Japan in 2003. He is currently on 2004-2006 Board of Directors in ISPOR and the President of ISPOR Japan Chapter. He is also a founding member of ISPOR Asia Consortium. He has been enjoying many opportunities to speak to the international community. In November 2004, Peking University, China, invited him as an adjunct professor in the graduate Department of Health Economic and Management. He is also on the editorial board for PharmacoEconomics and the Journal of Medical Economics.

Bong-Min Yang PhD
Bong-Min Yang is a Professor of the School of Public Health at Seoul National University, Korea. He received his BA (Economics) from Seoul National University and his Ph.D. in Economics from Penn State University in 1982. He had been Takemi Fellow at Harvard School of Public Health during 1989-90 and 1995-96 periods. He currently is the Dean of the School of Public Health, Seoul National University. Professor Yang has written extensively in health economics and health care system in Korea and East Asia. His recent publication includes, "Cost of Chronic Hepatitis B in South Korea,” Journal of Clinical Gastroenterology (2004), "Cost-effectiveness of Long-term Care Services in South Korea,” in Archives of Gerontology and Geriatrics (2005), “Impact of Outof- pocket Payment in Outpatient Care in Korea” (2005) in Health Policy. In addition to his research and publication, Professor Yang has worked as short-term consultant at WHO, UNDP, and the World Bank. For the Korean government, he served as a member of the Presidential Commission on Policy and Evaluation (1992-96), and Chairperson of Health Insurance Reform Committee (2003-2004). He currently is serving as Chairperson of the Pharmaceutical Pricing and Reimbursement Committee, Government of Korea, a research consultant to KIHASA, and a member of Executive Board of NHIC National Health Insurance Corporation).

Shu Chuen Li PhD, MBA, MApplSc, BPharm, Cert Health Econ., Grad Dip Bus (Tech Mgt)
Shu Chuen Li is an Associate Professor at National University of Singapore and Consultant and Visiting Specialist at the Centre for Pharmaceutical Administration, Health Sciences Authority, Republic of Singapore. Dr. Li is currently lecturing in clinical pharmacy practice at Department of Pharmacy, National University of Singapore (NUS). His main research interest is in the area of drug policy, pharmacoeconomics and outcomes research, especially in the area of HRQoL. Before taking up the current appointment with NUS, Dr. Li had served as Acting Director and Deputy Director of Pharmaceutical Evaluation Section, Pharmaceutical Benefits Branch, Commonwealth Department of Health and Family Services in Australia. Australia is the first country that applies pharmacoeconomic principles to drug regulation and introduced mandatory cost-effectiveness requirement for reimbursement of pharmaceuticals. In addition to lecturing at NUS, Dr. Li also serves as a member of the Singapore Ministry of Health Drug Advisory Committee (DAC), and as a consultant to Centre for Pharmaceutical Administration (CPA), Health Sciences Authority (HSA), Republic of Singapore. Dr. Li has also been engaged by the Pharmacy and Therapeutics Committee of National Healthcare Group (NHG) (a cluster of hospitals providing healthcare for half of the population in Singapore) as a consultant. Besides his experience in applied pharmacoeconomics, drug regulation and healthcare policy, Dr. Li has many years of experience in clinical pharmacy practice, especially in the areas of drug information, clinical trial and applied pharmacokinetics.

Viroj Tangcharoensathien PhD
After medical graduate from Mahidol University in 1979 Dr. Viroj Tangcharoensathien worked as medical officer and administrator in several remote district hospitals in Ubon Ratchatani Province for the period of 1980-87. Professor Prawase Vasi supported him through a Rockefeller Foundation Grant to pursue his Ph.D. in health economics and financing at the London School of Hygiene and Tropical Medicine in 1980-90. Upon returning from the UK, he worked in the Health Planning Division of the Ministry of Public Health (1991-94) before being seconded by the Ministry of Public Health to work as a full-time health policy researcher at the Health Systems Research Institute. He got Woodruff Medal 1991 Award for the outstanding Ph.D. thesis of the London School of Hygiene and Tropical Medicine, University of London, for his thesis title: Community Financing : the Urban Health Card in Chiang Mai. Thailand. He served in several positions in international forums such as the Member, Science and Technical Advisory Committee of UNDP/World Bank/ WHO Special Program for Research and Training in Tropical Diseases 1998-2000, Editorial Board member: Health Policy and Planning Journal, London School of Hygiene and Tropical and Tropical Medicine, Reproductive Health Matters, anonymous referee in international peer review journals i.e. Social Science and Medicine (1997-), Health Policy and Planning (1999-), the Bulletin of World Health Organization (200-), Human Resource Development Journal (1998-) and several other national Thai journals (1992-.) He was Chairperson of an Independent Review Committee for the Global Alliance on Vaccine and Immunization (GAVI); UNICEF -Geneva; (2000-04) and chair of Independent Review Committee of Health Metric Network (2005-) He got a Senior Research Scholar Institutional Grant on Health Economics and Financing, funded by the Thailand Research Fund (1998-2005). He is head of International Health Policy Program for which more than ten young committed researchers were mentored and supported to the Ph.D. level; three post-doctoral researchers were affiliated with the Program. The program aims to build up health policy and systems research capacity and ensure evidence were translated into policy and practices.

Aamir Hameed MBBS, BSc, FCPS (Internal Medicine), FCPS (Cardiology)
Dr. Aamir Hameed is a Senior Instructor and Consultant Cardiologist at the Aga Khan University, Karachi, Pakistan. He is currently, the Medical Director of the Coronary Critical care Units (CCU) of the Department of Medicine at the Aga Khan University Hospital. His area of research interest is hypertension, cardiac arrhythmias and evaluation of syncope. He is member of the Pakistan Hypertension League (PHL) and the Pakistan Cardiac Society (PCS), where he has been active on the scientific council on atherosclerosis and thrombosis of the PCS and has was one of the key members of the task force that helped write the first National guidelines on Unstable Angina/Non ST elevation myocardial Infarction. He is also consultant to the Smart Heart Program, which is the preventive cardiology program of the University and the Aga Khan Health services and has helped write guidelines and design, coordinate and facilitate workshops on various topics to disseminate preventive cardiology knowledge to primary care physicians and health care workers. He has contributed to scientific journals regularly and has been an invited speaker on many occasions. He has also contributed to newspapers on health awareness issues and health matters. In appreciation of his over all service he was awarded the “best cardiology faculty award 2005”. He has recently been accepted as member on the Executive Committee of the Asia Consortium of the International Society of Pharmacoeconomics and Outcomes Research.

Syed Mohamed Aljunid PhD, MD, MSc, FAMM
Dr. Syed Mohamed Aljunid is Professor of Health Economics and Senior Consultant in Public Health Medicine. Presently, he is the Head of Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM). He obtained his MD from UKM, Master of Science in Public Health from National University of Singapore and PhD in Health Economics and Financing Programme, London School of Hygiene and Tropical Medicine. He is a Fellow of Academy of Medicine Malaysia. He served as consultants to World Health Organisations in WPRO, SEARO and EMRO on a number of occasions on health economics and financing. He is involved in a number of research projects in health economics and financing. These include Case-Mix Methodology for Resources Allocations, Research on Impact of Managed Care on Primary Care Services, Socio-economic Impact of Psychiatric Disorders, Cost Effectiveness Analysis of Management of Schizophrenia, Cost-effectiveness of Trauma Services in Malaysia and Economic Evaluation of OPV/IPV Immunisation. He has published widely in referred journals both local and abroad in areas of health economics and public health in general. He is currently the Chief Editor of Journal of Community Health and has served in editorial board of Journal of Public Health Medicine.

 

Jawahar S. Bapna Phd, MD, MB
Dr. Bapna, a pharmacologist with medical background, is Professor Health and Pharmaceutical Management and Chairman of Ethics committee of BM Cancer Hospital and Research Centre, Jaipur. Trained at NIH, Washington DC, and IHCAR, Stockholm he has an extensive experience in training in health management, health planning and administration. He is an experienced evaluator and has functioned as team leader in a numbers of health systems projects. Dr. Bapna has particular experience in strategic planning and management programme at project level including health systems research in the context of health sector reform e.g. assisted EU review at Cambridge.

With more than 30 years experience, he has conducted extensive field surveys, data collection and management for research projects of agencies like WHO, World Bank, EU, and worked with a number of external companies, such as Euro Health Group, MSH etc., at primary care level. He is a trained facilitator and has experience of working as a part of multidisciplinary team emphasizing a participatory approach.

He has several years of experience of working with essential drugs and vaccines programmes under WHO-India Essential Drugs Programme as Vice President of Delhi Society for Promotion of Rational Use of Drugs. He has contributed to the development of drug policy, specifically to the essential drugs selection, logistics and procurement, and information through formulary, STGs as well as monitoring and evaluation for the states of Uttar Pradesh, Madhya Pradesh, Punjab, Jharkhand and Rajasthan.
 

Renuka Kulkarni Munshi MD (Pharmacology)
Dr. Renuka Kulkarni Munshi is Senior Lecturer at Department of Clinical Pharmacology, TN Medical College & BYL Nair Charitable Hospital, Mumbai, India. She sas conducted a number of GCP based clinical studies as well as experimental projects on a number of drugs, both allopathic as well as herbal. Is actively involved in a number of projects for WHO & Government organizations. She is actively involved in promoting rational drug use among medical students and practitioners and has co-organized several training programmers on rational drug use in Mumbai for medical students, medical teachers, pharmacists and medical officers. In addition she has coorganized and served as faculty on courses pertaining to Good Clinical Practices, research methodology and scientific communications. She has also helped prepare the Standard Treatment Guidelines for outdoor and admitted patients for the Municipal Corporation of Greater Mumbai. Dr. Munshi has participated in various WHO training courses such as the 2nd ICIUM held in Chiang Mai,Thailand in 2004; Pharmacovigilance course, WHO, Uppsala Sweden 2003; Drugs and Therapeutic Committee, WHO course, Mumbai, 2002; and Pharmacoeconomics course, WHO, Delhi & Jaipur 2002. Dr. Munshi's research areas include Rational use of drugs, antitubercular effects of Indian Medicinal Plants, clinical research and new drug development, Pharmacovigilance and Therapeutic drug monitoring. Has attended and presented original research papers at a number of workshops and conferences. She has been on the Organising Committee for various workshops and conferences like the ICMR workshop in Clinical Pharmacology being held at the department of Clinical Pharmacology every year and Update Ayurveda which is held every 4 years.

Wen Chen PhD, MD
Dr. Wen Chen is Professor and graduate student advisor. He received his PhD degree in social medicine and health management from the Shanghai Medical University in 1998. He attended the University of California at Berkeley in 2000 as a research fellow. Currently he serves as the Deputy Dean of the School of Public Health at Fudan University. His main research interests include health insurance, pharmaceutical economics and policy, and the economics of prevention. He has conducted projects sponsored by the National Natural Science Foundation of China, the Alliance for Health Policy and Systems Research, and the Ministry of Health. He has published more than 50 academic papers.

Michael Drummond BSc, MCom, DPhil
Dr. Michael Drummond is Professor of Health Economics and former Director of the Centre for Health Economics at the University of York. His particular field of interest is in the economic evaluation of health care treatments and programmes. He has undertaken evaluations in a wide range of medical fields including care of the elderly, neonatal intensive care, immunization programmes, services for people with AIDS, eye health care and pharmaceuticals. He is the author of two major textbooks and more than 500 scientific papers, has acted as a consultant to the World Health Organization and was Project Leader of a European Union Project on the Methodology of Economic Appraisal of Health Technology. He has been President of the International Society of Technology Assessment in Health Care, and a board member of the International Society for Pharmacoeconomics and Outcomes Research. He is currently a member of the Guidelines Review Panels of the National Institute for Clinical Excellence (NICE) in the UK, and is also Vice-President (European Operations) of Innovus Research Inc. From July 2006 he will be President of the International Society for Pharmacoeconomics and Outcomes Research.

Suzanne Hill PhD
Dr. Suzanne Hill has recently taken up the position of Secretary to the WHO Expert Committee on Essential Medicines, at the World Health Organisation in Geneva. Prior to that she was Associate Professor in Clinical Pharmacology at the University of Newcastle, Australia. In the position she was director of the Newcastle Evaluation Group, which provided pharmacoeconomics advice to the Pharmaceutical Benefits Advisory Committee of the Australian Department of Health. Dr. Hill's research interests are the public health aspects of clinical pharmacology, including drug regulation and pharmacoeconomics and she has many publications in relation to these topics. In addition she has provided international post-graduate short course training programs for health care workers in the use of economic evaluation in improving access to medicines in South Africa, Thailand, India and Hungary and the Baltic States. Dr. Hill has worked as consultant for the World Health Organization in a number of countries, including South Africa, Bulgaria, the Baltic countries, and Vietnam, in areas relating to national medicinal drug policy, including essential drugs lists, drug regulation and pharmacoeconomics, and developing international standard treatment guidelines for hypertension and malaria.

2nd Asia Pacific Conference Index Page